Middle East And Africa Blood Glucose Monitoring Market Industry: Market Size & Forecast 2026

The blood glucose monitoring market in the Middle East and Africa covers products used by diabetic patients and healthcare providers to track blood sugar levels for diabetes management. The overall market was valued at approximately $1.4 billion in 2025 and encompasses self-monitoring blood glucose devices, test strips, and continuous glucose monitoring systems used across clinical and home settings. Growth is supported by rising diabetes prevalence and expanding healthcare infrastructure throughout both regions.

• •The market includes traditional finger-prick testing devices, consumables such as test strips, and sensor-based continuous glucose monitors
• •Diabetes affects millions across the region, with prevalence increasing alongside urbanization, aging populations, and lifestyle changes
• •Healthcare spending growth and government initiatives are expanding patient access to diabetes management tools

Rising diabetes prevalence is the primary market driver, with increasing urbanization, sedentary lifestyles, and dietary changes contributing to higher incidence rates across both regions. Greater awareness among patients and physicians of the importance of tight glycemic control is encouraging adoption of regular glucose monitoring practices. Improving healthcare infrastructure, expanding insurance coverage, and rising disposable incomes are further supporting market expansion.

• •Growing prevalence of type 2 diabetes linked to obesity, urban migration, and aging populations
• •Increasing patient and healthcare provider education about complications associated with uncontrolled glucose levels
• •Government health initiatives and expanding medical insurance coverage improving device accessibility and affordability

The market is segmented primarily into self-monitoring blood glucose devices and continuous glucose monitoring systems, with the latter experiencing significantly faster growth rates. Self-monitoring devices and consumables represent the largest category by unit volume, while continuous monitoring is gaining share driven by technological advances and clinical evidence. Within the broader regional market, Gulf Cooperation Council countries typically account for a substantial share due to higher healthcare spending and diabetes prevalence.

• •Self-monitoring devices remain dominant by volume, while continuous glucose monitoring is the fastest-growing segment with double-digit growth rates
• •Gulf markets lead in adoption rates, with South Africa, Nigeria, Kenya, and the UAE representing key national markets
• •Urban centers with established healthcare systems show highest penetration, while rural and underserved areas present expansion opportunities

What are the recent trends and outlook?

Technology integration and product miniaturization are shaping the future of glucose monitoring in the region. Connectivity features enabling smartphone integration, cloud data storage, and real-time sharing with healthcare providers are gaining traction among tech-savvy patients. The market is expected to continue expanding as continuous monitoring adoption increases and pricing becomes more accessible, potentially shifting the product mix over the forecast period.

• •Smartphone-connected devices and app-based glucose tracking are gaining adoption among younger, tech-oriented patient populations
• •Prices for continuous glucose monitoring systems are expected to become more competitive as additional manufacturers enter the market
• •Telemedicine and remote patient monitoring integration may expand device access in underserved and geographically dispersed areas